UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,332,206 | +39.6% | 380,600 | +3.1% | 0.03% | +57.1% |
| Q2 2023 | $3,820,237 | +8.6% | 369,105 | -3.0% | 0.02% | -12.5% |
| Q1 2023 | $3,516,744 | +4.2% | 380,600 | 0.0% | 0.02% | +50.0% |
| Q4 2022 | $3,375,922 | +6.6% | 380,600 | 0.0% | 0.02% | -15.8% |
| Q3 2022 | $3,167,000 | +1.6% | 380,600 | 0.0% | 0.02% | -60.4% |
| Q2 2022 | $3,117,000 | +76.5% | 380,600 | +701.7% | 0.05% | +433.3% |
| Q4 2017 | $1,766,000 | – | 47,473 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |